-
Plan for this upcoming FA webinar!
In two weeks, on Wednesday, June 11th,
Design Therapeutics will host a webinar with speaker Chris Storgard, Chief Medical Officer at Design Therapeutics. He will be discussing the FA GeneTAC® DT-216P2 program and upcoming clinical trials.
This is a promising treatment to increase frataxin levels and to benefit those living with FA!
Do you have any questions for the presenters?
To register for the webinar, click the link below:
https://us02web.zoom.us/webinar/register/WN_kjTCGheIRcOSEuZmy5fF5w#/registration
-
0 Replies
Sorry, there were no replies found.
Log in to reply.